Comt val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor (Science. — 2003. —Feb. 21. — 299(5610). — P. 1240—1243: англ.)

J. Zubieta; Zubieta J.; M. Heitzeg; Heitzeg M.; Y. Smith; Smith Y.; J. Bueller; Bueller J.; K. Xu; Xu K.; Y. Xu; Xu Y.; R. Коерре; Коерре R.; C. Stohler; Stohler C.; D. Goldman; Goldman D.

doi:10.17816/nb89679

Comt val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor (Science. — 2003. —Feb. 21. — 299(5610). — P. 1240—1243: англ.)

Authors: Zubieta J.¹, Heitzeg M.¹, Smith Y.¹, Bueller J.¹, Xu K.¹, Xu Y.¹, Коерре R.¹, Stohler C.¹, Goldman D.¹
Affiliations:
1. University of Michigan
Issue: Vol XXXV, No 1-2 (2003)
Pages: 78-78
Section: Abstracts
URL: https://journals.rcsi.science/1027-4898/article/view/89679
DOI: https://doi.org/10.17816/nb89679
ID: 89679

Cite item

Full Text

Abstract
Full Text
About the authors
References
Statistics

Abstract

The catechol-O-methyl-transferase (COMT) gene regulates the metabolic processes of the neurotransmitter dopamine and, through it, influences endorphins, which play an important role in the process of pain perception. It was found that the COMT gene with the amino acid valine (val158) is more active than the variant of the gene containing methionine (met158).